Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
ACTRIMS 2023
ISC 2023
EHC 2022
AES 2022
WSC 2022
ECTRIMS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Parkinson's Disease
0:51
How can continuous dopaminergic delivery improve outcomes in PD?
Eric Freire-Alvarez
• 16 Sep 2022
1:33
Unmet needs across movement disorders
Fabrizio Stocchi
• 16 Sep 2022
0:52
Long term effects of treating levodopa-induced dyskinesia with sub-anesthetic ketamine
Torsten Falk
• 17 Sep 2022
1:13
Extending the efficacy of levodopa in patients with Parkinson’s disease
Torsten Falk
• 17 Sep 2022
1:27
Targeting oligomeric species to combat Parkinson’s disease
Daniel Otzen
• 5 Sep 2022
2:02
Targeting glycation as a potential therapeutic avenue in Parkinson’s disease
Daniel Otzen
• 5 Sep 2022
3:22
Low-dose ketamine produces long-term reduction in levodopa-induced dyskinesia
Torsten Falk
1:34
PADOVA trial: prasinezumab in early Parkinson’s disease
Gennaro Pagano
• 17 Sep 2022
1:20
Strategies to improve early diagnosis of Parkinson’s disease
Jaslovleen Kaur
• 17 Sep 2022
1:13
Elucidating prognostic biomarkers in Parkinson’s disease
Jaslovleen Kaur
• 17 Sep 2022
3:33
How can mitochondrial dynamics and mitophagy affect neurodegeneration?
Serge Przedborski
• 16 Sep 2022
2:54
Identifying and characterizing non-motor fluctuations in PD
K. Ray-Chaudhuri
• 17 Sep 2022
2:24
Current challenges in PSP management
Rodolfo Savica
• 16 Sep 2022
2:33
Investigations into managing non-motor fluctuations
K. Ray-Chaudhuri
• 17 Sep 2022
3:30
Advancements in cell therapies for Parkinson’s disease
Serge Przedborski
• 16 Sep 2022
1:48
Follow-up studies of long COVID in patients with Parkinson’s disease
Susanne Schneider
• 19 Sep 2022
Previous
1
2
3
4
5
6
7
…
28
Next